168 related articles for article (PubMed ID: 21633298)
1. Expression of survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the uterine cervix.
Sukpan K; Settakorn J; Khunamornpong S; Cheewakriangkrai C; Srisomboon J; Siriaunkgul S
Int J Gynecol Cancer; 2011 Jul; 21(5):911-7. PubMed ID: 21633298
[TBL] [Abstract][Full Text] [Related]
2. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
3. Expression of PTEN and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation.
Lu D; Qian J; Yin X; Xiao Q; Wang C; Zeng Y
Br J Biomed Sci; 2012; 69(4):143-6. PubMed ID: 23310986
[TBL] [Abstract][Full Text] [Related]
4. C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix.
Ohwada M; Wada T; Saga Y; Tsunoda S; Jobo T; Kuramoto H; Konno R; Suzuki M
Eur J Gynaecol Oncol; 2006; 27(1):53-5. PubMed ID: 16550970
[TBL] [Abstract][Full Text] [Related]
5. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
6. Adenoid basal carcinoma of the uterine cervix: clinicopathologic features of 12 cases with reference to CD117 expression.
Chen TD; Chuang HC; Lee LY
Int J Gynecol Pathol; 2012 Jan; 31(1):25-32. PubMed ID: 22123720
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
[TBL] [Abstract][Full Text] [Related]
9. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
10. High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Ye Y; Zhang S; Chen Y; Wang X; Wang P
Pathol Res Pract; 2018 Feb; 214(2):268-272. PubMed ID: 29103772
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
12. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
[TBL] [Abstract][Full Text] [Related]
13. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for small cell neuroendocrine carcinoma of the uterine cervix: an institutional experience.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Chandacham A; Sukpan K; Patumanond J
Int J Gynecol Cancer; 2014 Feb; 24(2):272-9. PubMed ID: 24401981
[TBL] [Abstract][Full Text] [Related]
15. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
17. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
19. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
Cheng KY; Wang ZL; Gu QY; Hao M
PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of c-KIT oncogene in high grade neuroendocrine carcinoma of the uterine cervix: Analysis of twelve cases.
Tsai WC; Chen CK; Han CP; Chao WR
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):581-582. PubMed ID: 31307758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
